Results 41 to 50 of about 133,668 (277)

THE DEVELOPMENT OF UKRAINIAN MEDICAL SCIENTIFIC ORGANIZATION THROUGH THE CENTURIES (ON THE 120th ANNIVERSARY OF ITS FOUNDING)

Праці Наукового товариства імені Шевченка. Медичні науки, 2018
Introduction. February 7th, 2018 marks 120 years since the foundation of the first Ukrainian medical scientific society “The Medical Commission of the Shevchenko Scientific Society.” Its original periodical journal  “Medical Collection” was initiated ...
Oksana Zayachkivska, Vassyl Lonchyna
doaj   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Information Outlook, May 2004 [PDF]

, 2004
Volume 8, Issue 5https://scholarworks.sjsu.edu/sla_io_2004/1004/thumbnail ...
Special Libraries Association
core   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Special Libraries, December 1940 [PDF]

, 1940
Volume 31, Issue 10https://scholarworks.sjsu.edu/sla_sl_1940/1009/thumbnail ...
Special Libraries Association
core   +1 more source

Natural language processing [PDF]

, 2003
Beginning with the basic issues of NLP, this chapter aims to chart the major research activities in this area since the last ARIST Chapter in 1996 (Haas, 1996), including: (i) natural language text processing systems - text summarization, information ...
Adams, Amsler, Bangalore, Barker, Benoît, Bian, Bondale, Carrick, Ceric, Chandrasekar, Chang, Charniak, Chen, Chowdhury, Chowdhury, Costantino, Cowie, Craven, Craven, Craven, Dogru, Evans, Feldman, Fernandez, Gaizauskas, Glasgow, Haas, Hayes, Hayes, Hedlund, Herath, Ide, Isahara, Jelinek, Jeong, Jurafsky, Kazakov, Kehler, Khoo, Kim, King, Lange, Lee, Lehmam, Lehtokangas, Lewis, Liddy, Liddy, Lovis, Ma, Magnini, Mani, Manning, Marquez, Martinez, Martinez, McMurchie, Meyer, Mihalcea, Mock, Moens, Morin, Narita, Nerbonne, Oard, Ogura, Oudet, Owei, Paris, Pasero, Pedersen, Perez-Carballo, Petreley, Pirkola, Poesio, Rosenfield, Roux, Say, Scarlett, Schenker, Silber, Smeaton, Smeaton, Smith, Sokol, Song, Sparck Jones, Staab, Stock, Tolle, Trybula, Tsuda, Vickery, Waldrop, Warner, Weigard, Wilks, Wong, Yang, Yang, Zadrozny, Zweigenbaum   +101 more
core   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Special Libraries, February 1940 [PDF]

, 1940
Volume 31, Issue 2https://scholarworks.sjsu.edu/sla_sl_1940/1001/thumbnail ...
Special Libraries Association
core   +5 more sources

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source